Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Etoposide Market : An Objective Assessment Of The Trajectory Of The Market 2024

Author: Shreyash Girdhar
by Shreyash Girdhar
Posted: Feb 24, 2019

Global Etoposide Market: Description

Etoposide is a derivative of epipodophyllotoxins that are derived from Mandragora officianarum (plant). Its chemical name is 4?-demethyl-epipodophylotoxin 9-[4,6-O-(R)-ethylidene-?-D-glucopyranoside] and it was introduced in the market in 1970. Currently, it is utilized extensively in manufacturing drugs that help treat various human malignant diseases such as testicular cancer, lymphomas (Hodgkin, non-Hodgkin), leukemia and lung cancer. Other diseases that are treated by consumption of etoposide include Ewing sarcoma, Kaposi disease, rhabdomyosarcoma, soft tissue sarcoma, pediatric brain tumors, gastric cancer, Wilms tumor, multiple myeloma, hepatoma, adenocarcinoma and uterine cancer.

Read Report Overview @ https://www.transparencymarketresearch.com/etoposide-market.html

Etoposide acts by inhibiting the activity of topoisomerase II which is responsible for uncoiling of deoxyribonucleic acid (DNA) and thus affects the deoxyribonucleic acid (DNA) replication and repair. Etoposide is usually administered in combination with various antineoplastic drugs such as cisplatin that have different modes of action. Etoposide is administered in the patient’s body through oral and intravenous routes. Intravenous administration of etoposide is given under the supervision of a doctor since overdose of the same might result in malfunctioning of human body. Etoposide solution for injection is available in 5 mL vial, 25 mL vial and 50 mL vial, and the dose is 20 mg/mL. Etoposide injections are usually given to patients whose cancer condition have not improved or have worsened post radiation treatment or other medications.

Global Etoposide Market: Major Products

Etopophos, Toposar and Vepesid are some of the branded versions of the Etoposide. Among all these, Etopophos accounts for the largest revenue share in the total etoposide market. Rising incidence of lung cancer has been considered as one of the major factors driving the market for etoposide. According to the American Lung Association (ALA), an estimated 159,260 people with lung cancer are expected to die in the American region in 2014 that will account for approximately 27% of all cancer deaths in the same year. Also, increasing incidence of Ewing sarcoma will propel the growth of etoposide market.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12344

Global Etoposide Market: Drivers and Restraints

The increasing number of acquired immune deficiency syndrome (AIDS) patients across the globe will further drive the growth of etoposide market as people with AIDS are at the high risk of developing Kaposi’s sarcoma. It has been estimated by the World Health Organization that in 2012, around 35.3 million people were living with AIDS worldwide; of these around 1.6 million people died. AIDS also increases the risk for Hodgkin and non-Hodgkin syndrome. Increasing number of patients suffering with gastric cancer will also augment the growth of etoposide market.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Rohit Bhisey

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

About the Author

But when people list out all their accomplishments in their bios, they risk sounding a little egotistical. Sure, you might impress a handful of people with all those laurels, but many people who read your bio will end up feeling eit

Rate this Article
Leave a Comment
Author Thumbnail
I Agree:
Comment 
Pictures
Author: Shreyash Girdhar

Shreyash Girdhar

Member since: Oct 30, 2018
Published articles: 777

Related Articles